Pavmed Inc
(PAVM)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -33,426 | -18,512 | -79,263 | -61,855 | -40,106 |
| Depreciation Amortization | 891 | 586 | 2,932 | 2,207 | 1,474 |
| Accounts receivable | -158 | -6 | -44 | -18 | -24 |
| Accounts payable and accrued liabilities | -553 | -301 | -918 | -538 | -1,541 |
| Other Working Capital | -44 | 378 | 1,591 | -533 | -1,916 |
| Other Operating Activity | 8,525 | 4,746 | 23,666 | 20,575 | 13,040 |
| Operating Cash Flow | $-24,765 | $-13,109 | $-52,036 | $-40,162 | $-29,073 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -45 | -42 | -242 | -59 | -41 |
| Purchase Sale Intangibles | N/A | N/A | 1,000 | 1,000 | 1,000 |
| Other Investing Activity | 0 | 0 | 1,000 | 1,000 | 1,000 |
| Investing Cash Flow | $-45 | $-42 | $758 | $941 | $959 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | -531 | N/A | 9,921 | 10,000 | 10,000 |
| Debt Repayment | N/A | -322 | N/A | N/A | N/A |
| Common Stock Issued | 1,403 | 1,205 | 2,627 | 2,260 | 1,908 |
| Other Financing Activity | 29,798 | 18,165 | 18,625 | 13,625 | 13,625 |
| Financing Cash Flow | $30,670 | $19,048 | $31,173 | $25,885 | $25,533 |
| Beginning Cash Position | 19,639 | 19,639 | 39,744 | 39,744 | 39,744 |
| End Cash Position | 25,499 | 25,536 | 19,639 | 26,408 | 37,163 |
| Net Cash Flow | $5,860 | $5,897 | $-20,105 | $-13,336 | $-2,581 |
| Free Cash Flow | |||||
| Operating Cash Flow | -24,765 | -13,109 | -52,036 | -40,162 | -29,073 |
| Capital Expenditure | -45 | -42 | -242 | -59 | -41 |
| Free Cash Flow | -24,810 | -13,151 | -52,278 | -40,221 | -29,114 |